Topic

Pennsylvania

A collection of 524 issues

How Long Does It Take to Get Cabometyx (Cabozantinib) Approved by Aetna CVS Health in Pennsylvania? Complete Timeline Guide

Answer Box: Cabometyx (Cabozantinib) Approval Timeline for Aetna CVS Health in Pennsylvania Cabometyx requires a formulary exception from Aetna CVS Health (excluded from Advanced Control formulary), taking 30-45 days for standard review or 72 hours for expedited cases. Pennsylvania residents benefit from a state external review program with 53% success

Blue Cross Blue Shield Pennsylvania Coverage for Vimizim (Elosulfase Alfa): Prior Authorization Requirements and Appeals Process

Quick Answer: To get Vimizim (elosulfase alfa) covered by Blue Cross Blue Shield in Pennsylvania, you need prior authorization with confirmed MPS IVA diagnosis via enzyme testing, specialist prescription, and baseline functional measures like the 6-minute walk test. If denied, Pennsylvania's new external review process overturns 50% of

Myths vs. Facts: Getting Translarna (ataluren) Covered by UnitedHealthcare in Pennsylvania

Answer Box: Getting Translarna Covered by UnitedHealthcare in Pennsylvania Current Reality: Translarna (ataluren) lacks FDA approval and is not covered by UnitedHealthcare formularies as of 2026. However, you can still pursue coverage through prior authorization with strong clinical documentation. Pennsylvania's new Independent External Review Program has a 53%

How to Get Revcovi (Elapegademase) Covered by Aetna (CVS Health) in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Revcovi Coverage in Pennsylvania Aetna (CVS Health) requires prior authorization for Revcovi (elapegademase) in Pennsylvania. Your fastest path: 1) Confirm ADA-SCID diagnosis with enzyme/genetic testing, 2) Have your immunologist/hematologist submit PA through Aetna's provider portal with medical necessity letter citing FDA

The Requirements Checklist to Get Venclexta (venetoclax) Covered by Aetna (CVS Health) in Pennsylvania

Answer Box: Getting Venclexta (venetoclax) Covered by Aetna (CVS Health) in Pennsylvania Aetna (CVS Health) requires prior authorization for Venclexta with documented BTK inhibitor failure for CLL/SLL and combination therapy for AML. Submit PA through CVS Caremark portal with complete TLS prevention plan, diagnosis confirmation, and prior therapy records.

How to Get Kesimpta (Ofatumumab) Covered by UnitedHealthcare in Pennsylvania: Prior Authorization, Appeals, and Cost-Saving Strategies

Quick Answer: Getting Kesimpta Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Kesimpta (ofatumumab) through OptumRx, typically mandating step therapy with other disease-modifying therapies first. Your neurologist submits the PA via UHC Provider Portal with MS diagnosis (ICD-10 G35), prior DMT failures, and baseline labs. Standard decisions take

Cigna's Coverage Criteria for Soliris (Eculizumab) in Pennsylvania: What Counts as "Medically Necessary"?

Answer Box: Getting Soliris Covered by Cigna in Pennsylvania Cigna requires prior authorization for Soliris (eculizumab) with specific diagnostic tests, meningococcal vaccinations ≥2 weeks before treatment, and prescriber REMS enrollment. For PNH, you need flow cytometry showing GPI-anchored protein deficiency; for myasthenia gravis, positive anti-AChR antibodies; for NMOSD, positive anti-AQP4

How to Get Tavneos (Avacopan) Covered by Humana in Pennsylvania: Timeline, Forms & Appeals Process

Answer Box: Getting Tavneos (Avacopan) Covered by Humana in Pennsylvania Humana requires prior authorization for Tavneos (avacopan) with documentation of severe active ANCA-associated vasculitis, positive ANCA testing, and specialist prescriber (rheumatologist, nephrologist, or pulmonologist). Submit via Humana's provider portal or call 800-555-2546 for expedited review (72 hours). If

How to Get Mycapssa (Octreotide Oral) Covered by Humana in Pennsylvania: Complete Prior Authorization Guide

Quick Answer: Getting Mycapssa Covered by Humana in Pennsylvania Mycapssa (oral octreotide) requires prior authorization from Humana Medicare Advantage plans in Pennsylvania. You'll need documented proof of acromegaly diagnosis, prior response to injectable somatostatin analogs (like Sandostatin LAR or Somatuline Depot), and an endocrinologist's prescription. If

How to Get Taltz (Ixekizumab) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide & Appeal Scripts

Quick Answer: Getting Taltz Covered in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Taltz (ixekizumab), typically including step therapy with at least one TNF inhibitor failure. Most commercial and health exchange plans classify Taltz as non-preferred, while Medicaid managed plans may offer preferred status. The